Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

February 19 - 21, 2015
La Jolla, CA

Dear Colleagues,

It is our pleasure to invite you to join us February 19 -21, 2015 in sunny La Jolla, California for the The 17th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer: Recent Advances and Future Directions in Basic and Clinical Cancer Research. This meeting promises to be a first-class educational event that focuses on both the clinical and research science in angiogenesis and immune therapies for cancer.

This conference will provide a comprehensive overview of the current understanding of anti-angiogenic and immune therapies for cancer and focus on the cutting edge science in the field, highlighting novel strategies under clinical development with potential for benefit. Through didactic presentations, debates, and interactive panel discussions and Q&A sessions, the conference will serve as a platform to resolve many of the research and clinical challenges for optimal integration of these agents into existing treatment paradigms, appropriate selection of patients based on biomarker profiles, and use of the agents in the adjuvant and advanced disease settings. Topics that will be deliberated by recognized experts in the field during this symposium include the rationale for and mechanisms of action of novel anti-angiogenic and immune-targeted strategies, stromal therapy and targets in the tumor microenvironment, combination regimens, controversies with the new therapeutics, mechanisms of resistance, unique adverse events, and ongoing clinical trials.   

With few other meetings of this type currently in the United States, this highly-relevant clinical conference will provide the basis to advance understanding of the most recent basic and clinical science research on angiogenesis and immune therapies for cancer.  The 17th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer: Recent Advances and Future Directions in Basic and Clinical Cancer Research will be the premiere educational event. We look forward to seeing you in February, for what is sure to be an educational and informative scientific meeting!



George W. Sledge, Jr., MD 
Stanford University School of Medicine
Stanford, California

Robert S. Kerbel, PhD 
Sunnybrook Research Institute
Odette Cancer Centre 
University of Toronto
Toronto, Ontario, Canada

Lee M. Ellis, MD 
The University of Texas 
MD Anderson Cancer Center
Houston, Texas

Axel Grothey, MD 
Mayo Clinic
Rochester, Minnesota

Helen X. Chen, MD 
National Cancer Institute
Rockville, Maryland

Elizabeth M. Jaffee, M.D.
The Sidney Kimmel Cancer Center 
Johns Hopkins
Baltimore, Maryland

Important Dates

Early Registration Deadline December 18, 2014
Abstract Submission Deadline December 22, 2014
Abstract Notifications Mailed
January 12, 2015
Abstract Presenter Registration Deadline January 29, 2015
Discounted Registration Deadline February 5, 2015
Presentation Dates February 19 – 21, 2015